1. Home
  2. ZLAB vs TEX Comparison

ZLAB vs TEX Comparison

Compare ZLAB & TEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • TEX
  • Stock Information
  • Founded
  • ZLAB 2013
  • TEX 1933
  • Country
  • ZLAB China
  • TEX United States
  • Employees
  • ZLAB N/A
  • TEX N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • TEX Construction/Ag Equipment/Trucks
  • Sector
  • ZLAB Health Care
  • TEX Industrials
  • Exchange
  • ZLAB Nasdaq
  • TEX Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • TEX 3.0B
  • IPO Year
  • ZLAB 2017
  • TEX N/A
  • Fundamental
  • Price
  • ZLAB $36.14
  • TEX $39.18
  • Analyst Decision
  • ZLAB Buy
  • TEX Hold
  • Analyst Count
  • ZLAB 3
  • TEX 11
  • Target Price
  • ZLAB $47.37
  • TEX $56.80
  • AVG Volume (30 Days)
  • ZLAB 1.3M
  • TEX 1.0M
  • Earning Date
  • ZLAB 05-07-2025
  • TEX 04-24-2025
  • Dividend Yield
  • ZLAB N/A
  • TEX 1.72%
  • EPS Growth
  • ZLAB N/A
  • TEX N/A
  • EPS
  • ZLAB N/A
  • TEX 4.96
  • Revenue
  • ZLAB $398,988,000.00
  • TEX $5,127,000,000.00
  • Revenue This Year
  • ZLAB $45.57
  • TEX $6.38
  • Revenue Next Year
  • ZLAB $47.91
  • TEX $4.14
  • P/E Ratio
  • ZLAB N/A
  • TEX $7.98
  • Revenue Growth
  • ZLAB 49.59
  • TEX N/A
  • 52 Week Low
  • ZLAB $13.48
  • TEX $36.15
  • 52 Week High
  • ZLAB $37.99
  • TEX $68.08
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 64.46
  • TEX 35.98
  • Support Level
  • ZLAB $34.32
  • TEX $39.00
  • Resistance Level
  • ZLAB $37.99
  • TEX $42.15
  • Average True Range (ATR)
  • ZLAB 1.98
  • TEX 1.86
  • MACD
  • ZLAB 0.02
  • TEX -0.02
  • Stochastic Oscillator
  • ZLAB 72.51
  • TEX 39.56

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

About TEX Terex Corporation

Terex is a top manufacturer of aerial work platforms, materials processing equipment, and specialty equipment, such as material handlers, cranes, and concrete mixer trucks. Its current composition is a result of numerous acquisitions over several decades and a recent shift to focus on its two core segments after divesting a handful of underperforming businesses. Terex's remaining segments see heavy demand in nonresidential construction as well as in maintenance, manufacturing, energy, and materials management.

Share on Social Networks: